Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
23172 | 356 | 44.7 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
317 | 3 | HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA | 39408 |
2452 | 2 | HEPATOCYTE GROWTH FACTOR//C MET//HGF | 4045 |
23172 | 1 | RON//MACROPHAGE STIMULATING PROTEIN//RON RECEPTOR | 356 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RON | authKW | 2859020 | 20% | 48% | 70 |
2 | MACROPHAGE STIMULATING PROTEIN | authKW | 1921299 | 8% | 80% | 28 |
3 | RON RECEPTOR | authKW | 1372365 | 4% | 100% | 16 |
4 | HEPATOCYTE GROWTH FACTOR LIKE PROTEIN | authKW | 1286592 | 4% | 100% | 15 |
5 | MST1R | authKW | 1180391 | 5% | 81% | 17 |
6 | RECEPTEUR DORIGINE NANTAIS | authKW | 779751 | 3% | 91% | 10 |
7 | HGFL | authKW | 428864 | 1% | 100% | 5 |
8 | RON PROTEIN | authKW | 257318 | 1% | 100% | 3 |
9 | MSP | authKW | 224361 | 6% | 12% | 22 |
10 | RON RECEPTOR TYROSINE KINASE | authKW | 192987 | 1% | 75% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1857 | 38% | 0% | 135 |
2 | Cell Biology | 548 | 21% | 0% | 76 |
3 | Biochemistry & Molecular Biology | 435 | 31% | 0% | 112 |
4 | Genetics & Heredity | 161 | 10% | 0% | 36 |
5 | Immunology | 133 | 11% | 0% | 39 |
6 | Gastroenterology & Hepatology | 62 | 5% | 0% | 17 |
7 | Hematology | 52 | 4% | 0% | 16 |
8 | Medicine, Research & Experimental | 38 | 5% | 0% | 18 |
9 | Biophysics | 36 | 5% | 0% | 17 |
10 | Developmental Biology | 22 | 2% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC BIOLSTATE DIAG TREATMENT INFE | 171546 | 1% | 100% | 2 |
2 | CHANG JIANG OLAR ENDOWMENT BIOMED SCI | 171546 | 1% | 100% | 2 |
3 | CHEUNG KONG OLARS PROGRAM BIOMED SCI | 171546 | 1% | 100% | 2 |
4 | INFECT DIS CANC BIOL THER EUT | 171546 | 1% | 100% | 2 |
5 | AFFILIATED TEACHING HOSP 1 | 137232 | 1% | 40% | 4 |
6 | RIYADH BIOCHEM | 114362 | 1% | 67% | 2 |
7 | CU CANC | 110276 | 1% | 43% | 3 |
8 | AFFILIATED HOSP 1 CANC BIOL | 85773 | 0% | 100% | 1 |
9 | AFFILIATED HOSP 1 MEDPROGRAM TUMOR BIOL | 85773 | 0% | 100% | 1 |
10 | AFFILIATED HOSPTIAL 1 | 85773 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | STAND | 12252 | 0% | 14% | 1 |
2 | ONCOGENE | 2074 | 6% | 0% | 21 |
3 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY | 901 | 1% | 1% | 2 |
4 | MOLECULAR CANCER | 770 | 1% | 0% | 4 |
5 | JOURNAL OF LEUKOCYTE BIOLOGY | 593 | 2% | 0% | 7 |
6 | ADVANCES IN CANCER RESEARCH | 504 | 1% | 0% | 2 |
7 | CANCER BIOLOGY & THERAPY | 482 | 1% | 0% | 4 |
8 | CARCINOGENESIS | 461 | 2% | 0% | 8 |
9 | HUMAN CELL | 447 | 0% | 1% | 1 |
10 | AMERICAN JOURNAL OF CANCER RESEARCH | 431 | 1% | 0% | 2 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RON | 2859020 | 20% | 48% | 70 | Search RON | Search RON |
2 | MACROPHAGE STIMULATING PROTEIN | 1921299 | 8% | 80% | 28 | Search MACROPHAGE+STIMULATING+PROTEIN | Search MACROPHAGE+STIMULATING+PROTEIN |
3 | RON RECEPTOR | 1372365 | 4% | 100% | 16 | Search RON+RECEPTOR | Search RON+RECEPTOR |
4 | HEPATOCYTE GROWTH FACTOR LIKE PROTEIN | 1286592 | 4% | 100% | 15 | Search HEPATOCYTE+GROWTH+FACTOR+LIKE+PROTEIN | Search HEPATOCYTE+GROWTH+FACTOR+LIKE+PROTEIN |
5 | MST1R | 1180391 | 5% | 81% | 17 | Search MST1R | Search MST1R |
6 | RECEPTEUR DORIGINE NANTAIS | 779751 | 3% | 91% | 10 | Search RECEPTEUR+DORIGINE+NANTAIS | Search RECEPTEUR+DORIGINE+NANTAIS |
7 | HGFL | 428864 | 1% | 100% | 5 | Search HGFL | Search HGFL |
8 | RON PROTEIN | 257318 | 1% | 100% | 3 | Search RON+PROTEIN | Search RON+PROTEIN |
9 | MSP | 224361 | 6% | 12% | 22 | Search MSP | Search MSP |
10 | RON RECEPTOR TYROSINE KINASE | 192987 | 1% | 75% | 3 | Search RON+RECEPTOR+TYROSINE+KINASE | Search RON+RECEPTOR+TYROSINE+KINASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | YAO, HP , ZHOU, YQ , ZHANG, RW , WANG, MH , (2013) MSP-RON SIGNALLING IN CANCER: PATHOGENESIS AND THERAPEUTIC POTENTIAL.NATURE REVIEWS CANCER. VOL. 13. ISSUE 7. P. 466-481 | 120 | 75% | 36 |
2 | ZAREI, O , BENVENUTI, S , USTUN-ALKAN, F , HAMZEH-MIVEHROUD, M , DASTMALCHI, S , (2016) STRATEGIES OF TARGETING THE EXTRACELLULAR DOMAIN OF RON TYROSINE KINASE RECEPTOR FOR CANCER THERAPY AND DRUG DELIVERY.JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. VOL. 142. ISSUE 12. P. 2429 -2446 | 133 | 58% | 0 |
3 | WANG, X , HANKEY, PA , (2013) THE RON RECEPTOR TYROSINE KINASE: A KEY REGULATOR OF INFLAMMATION AND CANCER PROGRESSION.CRITICAL REVIEWS IN IMMUNOLOGY. VOL. 33. ISSUE 6. P. 549-574 | 104 | 51% | 7 |
4 | WAGH, PK , PEACE, BE , WALTZ, SE , (2008) MET-RELATED RECEPTOR TYROSINE KINASE RON IN TUMOR GROWTH AND METASTASIS.ADVANCES IN CANCER RESEARCH, VOL 100. VOL. 100. ISSUE . P. 1 -+ | 79 | 68% | 70 |
5 | BENIGHT, NM , WALTZ, SE , (2012) RON RECEPTOR TYROSINE KINASE SIGNALING AS A THERAPEUTIC TARGET.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 16. ISSUE 9. P. 921-931 | 66 | 75% | 8 |
6 | KRETSCHMANN, KL , EYOB, H , BUYS, SS , WELM, AL , (2010) THE MACROPHAGE STIMULATING PROTEIN/RON PATHWAY AS A POTENTIAL THERAPEUTIC TARGET TO IMPEDE MULTIPLE MECHANISMS INVOLVED IN BREAST CANCER PROGRESSION.CURRENT DRUG TARGETS. VOL. 11. ISSUE 9. P. 1157-1168 | 67 | 58% | 25 |
7 | KANG, CM , BABICKY, ML , LOWY, AM , (2014) THE RON RECEPTOR TYROSINE KINASE IN PANCREATIC CANCER PATHOGENESIS AND ITS POTENTIAL IMPLICATIONS FOR FUTURE TARGETED THERAPIES.PANCREAS. VOL. 43. ISSUE 2. P. 183 -189 | 52 | 65% | 6 |
8 | WANG, MH , YAO, HP , ZHOU, YQ , (2006) ONCOGENESIS OF RON RECEPTOR TYROSINE KINASE: A MOLECULAR TARGET FOR MALIGNANT EPITHELIAL CANCERS.ACTA PHARMACOLOGICA SINICA. VOL. 27. ISSUE 6. P. 641 -650 | 57 | 70% | 23 |
9 | O'TOOLE, JM , RABENAU, KE , BURNS, K , LU, D , MANGALAMPALLI, V , BALDERES, P , COVINO, N , BASSI, R , PREWETT, M , GOTTFREDSEN, KJ , ET AL (2006) THERAPEUTIC IMPLICATIONS OF A HUMAN NEUTRALIZING ANTIBODY TO THE MACROPHAGE-STIMULATING PROTEIN RECEPTOR TYROSINE KINASE (RON), A C-MET FAMILY MEMBER.CANCER RESEARCH. VOL. 66. ISSUE 18. P. 9162-9170 | 36 | 84% | 68 |
10 | WANG, MH , WANG, D , CHEN, YQ , (2003) ONCOGENIC AND INVASIVE POTENTIALS OF HUMAN MACROPHAGE-STIMULATING PROTEIN RECEPTOR, THE RON RECEPTOR TYROSINE KINASE.CARCINOGENESIS. VOL. 24. ISSUE 8. P. 1291-1300 | 58 | 56% | 85 |
Classes with closest relation at Level 1 |